MINIMALLY INVASIVE SURGERY
+ The Challenge
Reducing the number of incisions and minimizing abdominal wall trauma is the next logical step in the evolution of laparoscopic surgery as it has the potential to offer significant benefits over traditional laparoscopy.
+ Ease-of-use limitations
Today, general adoption of single-port methods has been hindered by ease-of-use limitations, associated with the inability to achieve adequate triangulation for optimal surgical manipulation, retraction, and exposure. This results in poor ergonomics, long learning curves, prolonged operative times, and potential for increased risk of visceral injury and surgeon morbidity.
+ Issues from large incisions
In an attempt to overcome these ease-of-use limitations, current day technology involves access incisions of 20-30 or even 50+mm in length, creating controversy regarding higher rates of incisional hernia, increased post-operative pain, and slower recovery.
Delivering on the promise of single-port surgery
+ Small – 15mm access incision
FMX314 is the world’s first single-port platform that does not require a larger access incision than conventional laparoscopic surgery (15mm trocar compatible), addressing incisional hernia and post-operative pain concerns.
+ Simple – Improved triangulation
Achieving excellent triangulation and range of motion with hand orientation similar to conventional laparoscopy makes FMX314 easy to use, improving overall procedural efficiency and shortening learning curves.
+ Secure – Mimicking conventional laparoscopy
Closely mimicking conventional multi-port laparoscopy enables surgeons to perform procedural steps ergonomically, allowing for a comfortable and secure single-port approach.
A more productive and efficient advancement of innovative medical products.
+ The lean approach
Building on our established position as a stent industry leader with state-of-the-art laser cutting capabilities, we have the advantage of in-house control over the manufacturing of key components of the FMX314 platform.
Thanks to our network within the medical device industry, we are able to work with various professional service providers for the supply of other platform components and services. This allows us to outsource cost by leveraging their expertise and infrastructure.
+ Proprietary technology
- Today, the FMX314 platform is protected by a growing IP portfolio of 27 US and international patent applications in various stages of approval including 11 patents granted.
Our 15mm single-port surgery solution offers patients the potential for improved health outcomes, including fewer port-site complications, less post-operative pain, faster recovery and exceptional cosmesis.
Capturing the benefits of single-port surgery, our platform ultimately allows surgeons to provide better care, improving overall patient satisfaction. Also, the FMX314 offers surgeons the ability to comfortably perform single-port surgery in a manner closely mimicking traditional laparoscopy, enhancing ease-of-use and shortening learning curves.
+ Health system
Compatible for insertion through a single 15mm laparoscopic trocar, our platform potentially lowers hospital readmission rates to treat hernias and infections. Fewer incisions also accelerate recovery and return to the workplace, reducing the use of analgesics and improving overall procedural efficiency.
Pushing innovation, staying ahead of the curve.
+ Improving quality of life by creating novel devices
As a global market leader in contract stent manufacturing, we have been a trusted partner in the medical device industry for over 15 years. Fortimedix Surgical is committed to continuing the evolution of minimally invasive surgery by driving technological innovation across surgical specialties to improve the quality of life of patients throughout the world.
Well known for state-of-the-art manufacturing capabilities and operational excellence, we offer unsurpassed service and dedication to customer satisfaction. We are now applying our knowledge and extensive expertise to challenge the status quo in minimally invasive surgery by creating novel devices that capture the claimed benefits of single-port surgery.